Literature DB >> 28485549

Immune-related fulminant myocarditis in a patient receiving ipilimumab therapy for relapsed chronic myelomonocytic leukaemia.

David D Berg1, Muthiah Vaduganathan1, Anju Nohria1, Matthew S Davids2, Edwin P Alyea2, Matthew Torre3, Robert F Padera3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28485549     DOI： 10.1002/ejhf.806

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  13 in total

1.  Immune Checkpoint Inhibitor-Associated Myocarditis.

Authors:  Sarju Ganatra; Tomas G Neilan
Journal:  Oncologist       Date:  2018-05-25

Review 2.  Chest Pain in the Cancer Patient.

Authors:  Sara Tyebally; Aruni Ghose; Daniel H Chen; Aderonke T Abiodun; Arjun K Ghosh
Journal:  Eur Cardiol       Date:  2022-05-31

3.  Successful Therapy for Myocarditis Concomitant With Complete Heart Block After Pembrolizumab Treatment for Head and Neck Squamous Cell Carcinoma: A Case Report With Literature Review.

Authors:  Lina Su; Chuanfen Liu; Wenjie Wu; Yuxia Cui; Manyan Wu; Hong Chen
Journal:  Front Cardiovasc Med       Date:  2022-05-12

4.  Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action.

Authors:  Tomas G Neilan; Mace L Rothenberg; Laleh Amiri-Kordestani; Ryan J Sullivan; Richard M Steingart; William Gregory; Subramanian Hariharan; Tarek A Hammad; JoAnn Lindenfeld; Martin J Murphy; Javid J Moslehi
Journal:  Oncologist       Date:  2018-05-25

Review 5.  Modern-day cardio-oncology: a report from the 'Heart Failure and World Congress on Acute Heart Failure 2018'.

Authors:  Markus S Anker; Alessia Lena; Sara Hadzibegovic; Yury Belenkov; Jutta Bergler-Klein; Rudolf A de Boer; Alain Cohen-Solal; Dimitrios Farmakis; Stephan von Haehling; Teresa López-Fernández; Radek Pudil; Thomas Suter; Carlo G Tocchetti; Alexander R Lyon
Journal:  ESC Heart Fail       Date:  2018-12

6.  Circulating miR-4763-3p Is a Novel Potential Biomarker Candidate for Human Adult Fulminant Myocarditis.

Authors:  Xiang Nie; Mengying He; Jin Wang; Peng Chen; Feng Wang; Jinsheng Lai; Chenze Li; Ting Yu; Houjuan Zuo; Guanglin Cui; Kun Miao; Jiangang Jiang; Dao Wen Wang; Chen Chen
Journal:  Mol Ther Methods Clin Dev       Date:  2020-05-12       Impact factor: 6.698

7.  Comparative Transcriptomics of Immune Checkpoint Inhibitor Myocarditis Identifies Guanylate Binding Protein 5 and 6 Dysregulation.

Authors:  Daniel Finke; Markus B Heckmann; Janek Salatzki; Johannes Riffel; Esther Herpel; Lucie M Heinzerling; Benjamin Meder; Mirko Völkers; Oliver J Müller; Norbert Frey; Hugo A Katus; Florian Leuschner; Ziya Kaya; Lorenz H Lehmann
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

Review 8.  Immune checkpoint inhibitor-induced myocarditis in cancer patients: a case report and review of reported cases.

Authors:  Emma Matzen; Lars Erik Bartels; Brian Løgstrup; Stine Horskær; Christina Stilling; Frede Donskov
Journal:  Cardiooncology       Date:  2021-08-09

Review 9.  Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment.

Authors:  Nicolas Palaskas; Juan Lopez-Mattei; Jean Bernard Durand; Cezar Iliescu; Anita Deswal
Journal:  J Am Heart Assoc       Date:  2020-01-21       Impact factor: 5.501

Review 10.  Cardiotoxicity of Immune Checkpoint Inhibitors.

Authors:  Rushin P Patel; Rohan Parikh; Krishna S Gunturu; Rana Zouveenoor Tariq; Sourbha S Dani; Sarju Ganatra; Anju Nohria
Journal:  Curr Oncol Rep       Date:  2021-05-03       Impact factor: 5.075
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.